XT
IMRX icon

XTX Topco’s Immuneering IMRX Stock Holding History

XTX Topco’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-64,040
Closed -$448K – 3536
2025
Q3 		$448K Buy
64,040
+37,211
+139% +$193K 0.02% 1156
2025
Q2 		$90.4K Buy
+26,829
New +$46K ﹤0.01% 1902
2025
Q1 		– Sell
-32,650
Closed -$71.8K – 2710
2024
Q4 		$71.8K Buy
32,650
+20,871
+177% +$43.3K 0.01% 1833
2024
Q3 		$29.3K Sell
11,779
-22,380
-66% -$32.5K ﹤0.01% 1781
2024
Q2 		$43.7K Buy
34,159
+9,274
+37% +$15.2K ﹤0.01% 1524
2024
Q1 		$71.9K Buy
+24,885
New +$139K 0.01% 1411

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco's IMRX Position: Q4 2025 in Review

XTX Topco sold out of Immuneering (IMRX) in Q4 2025, closing a stake of 64,040 shares — an estimated $448K sold.

XTX Topco first reported a position in IMRX in Q1 2024 and held it in 6 quarters. The position peaked at $448K in Q3 2025. 86 funds tracked by Wall St. Rank hold IMRX as of Q4 2025.

  • XTX Topco reported no remaining Immuneering position as of Q4 2025 after selling out during the quarter.
  • XTX Topco sold 64,040 Immuneering shares in Q4 2025, an estimated $448K.
  • XTX Topco first reported a position in Immuneering in Q1 2024 and held it in 6 quarters.
  • XTX Topco's Immuneering position peaked at $448K in Q3 2025.
  • 86 funds tracked by Wall St. Rank held Immuneering as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.